Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 3
2004 3
2005 1
2006 1
2008 3
2009 3
2010 3
2011 2
2012 1
2013 2
2014 3
2015 5
2016 6
2017 4
2018 2
2019 6
2020 13
2021 9
2022 11
2023 11
2024 5
2025 12
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancers.
Chen Y, Ballarò R, Sans M, Thege FI, Zuo M, Dou R, Min J, Yip-Schneider M, Zhang J, Wu R, Irajizad E, Makino Y, Rajapakshe KI, Rudsari HK, Hurd MW, León-Letelier RA, Katayama H, Ostrin E, Vykoukal J, Dennison JB, Do KA, Hanash SM, Wolff RA, Guerrero PA, Kim M, Schmidt CM, Maitra A, Fahrmann JF. Chen Y, et al. Among authors: vykoukal j. Gut. 2025 Sep 8;74(10):1638-1652. doi: 10.1136/gutjnl-2025-335220. Gut. 2025. PMID: 40268349 Free PMC article.
Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progression.
León-Letelier RA, Chen Y, Dou R, Irajizad E, Yip-Schneider MT, Wu R, Ejaz R, Rudsari HK, Li Y, Spencer R, Ballarò R, Vykoukal J, Hurd M, Dennison JB, Do KA, Maitra A, Zhang J, Hanash S, Schmidt CM, Fahrmann JF. León-Letelier RA, et al. Among authors: vykoukal j. Clin Cancer Res. 2025 Jun 13;31(12):2454-2465. doi: 10.1158/1078-0432.CCR-24-2931. Clin Cancer Res. 2025. PMID: 40184234 Free PMC article.
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.
Fahrmann JF, Schmidt CM, Mao X, Irajizad E, Loftus M, Zhang J, Patel N, Vykoukal J, Dennison JB, Long JP, Do KA, Zhang J, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger J, Yip-Schneider MT, Maitra A, Wolpin BM, Hanash S. Fahrmann JF, et al. Among authors: vykoukal j. Gastroenterology. 2021 Mar;160(4):1373-1383.e6. doi: 10.1053/j.gastro.2020.11.052. Epub 2020 Dec 14. Gastroenterology. 2021. PMID: 33333055 Free PMC article. Clinical Trial.
A blood-based metabolomic signature predictive of risk for pancreatic cancer.
Irajizad E, Kenney A, Tang T, Vykoukal J, Wu R, Murage E, Dennison JB, Sans M, Long JP, Loftus M, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger JM, Maitra A, Do KA, Yu B, Wolpin BM, Hanash S, Fahrmann JF. Irajizad E, et al. Among authors: vykoukal j. Cell Rep Med. 2023 Sep 19;4(9):101194. doi: 10.1016/j.xcrm.2023.101194. Cell Rep Med. 2023. PMID: 37729870 Free PMC article.
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial.
Zhang X, Irajizad E, Hoffman KL, Fahrmann JF, Li F, Seo YD, Browman GJ, Dennison JB, Vykoukal J, Luna PN, Siu W, Wu R, Murage E, Ajami NJ, McQuade JL, Wargo JA, Long JP, Do KA, Lampe JW, Basen-Engquist KM, Okhuysen PC, Kopetz S, Hanash SM, Petrosino JF, Scheet P, Daniel CR. Zhang X, et al. Among authors: vykoukal j. EBioMedicine. 2023 Dec;98:104873. doi: 10.1016/j.ebiom.2023.104873. Epub 2023 Nov 30. EBioMedicine. 2023. PMID: 38040541 Free PMC article. Clinical Trial.
Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment.
Fahrmann JF, Marsh T, Irajizad E, Patel N, Murage E, Vykoukal J, Dennison JB, Do KA, Ostrin E, Spitz MR, Lam S, Shete S, Meza R, Tammemägi MC, Feng Z, Hanash SM. Fahrmann JF, et al. Among authors: vykoukal j. J Clin Oncol. 2022 Mar 10;40(8):876-883. doi: 10.1200/JCO.21.01460. Epub 2022 Jan 7. J Clin Oncol. 2022. PMID: 34995129 Free PMC article.
Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancer.
Vykoukal J, Chen Y, Zuo M, Ballarò R, Hong MJ, Krishna H, Rodriquez-Perera DB, Katayama H, Irajizad E, Wu R, León-Letelier RA, Dennison JB, Gutierrez AM, Paulucci-Holthauzen A, Thompson TC, Rusling L, Cai Y, Hsiao FC, Park S, Arun B, Hanash S, Fahrmann JF. Vykoukal J, et al. Cell Rep Med. 2025 Dec 16;6(12):102478. doi: 10.1016/j.xcrm.2025.102478. Cell Rep Med. 2025. PMID: 41406946 Free PMC article.
KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB.
Song S, Fan Y, Zou G, Huo L, Kumar J, Li Y, Wang R, Dai E, Jin J, Scott AW, Shao S, Pizzi MP, Vykoukal JV, Katayama H, Hanash S, Calin GA, Zhang X, Lee MG, Wang Z, Lo YH, Gan Q, Waters RE, Yin F, Wang L, Cheng X, Ajani JA, Dhar SS. Song S, et al. Among authors: vykoukal jv. Cancer Lett. 2025 Jul 1;621:217695. doi: 10.1016/j.canlet.2025.217695. Epub 2025 Apr 4. Cancer Lett. 2025. PMID: 40189014 Free PMC article.
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.
Geng C, Zhang MC, Manyam GC, Vykoukal JV, Fahrmann JF, Peng S, Wu C, Park S, Kondraganti S, Wang D, Robinson BD, Loda M, Barbieri CE, Yap TA, Corn PG, Hanash S, Broom BM, Pilié PG, Thompson TC. Geng C, et al. Among authors: vykoukal jv. Clin Cancer Res. 2023 Nov 1;29(21):4464-4478. doi: 10.1158/1078-0432.CCR-23-1439. Clin Cancer Res. 2023. PMID: 37581614 Free PMC article.
101 results